✦ LIBER ✦

KIF6 POLYMORPHISM AND THE EFFICACY OF STATIN THERAPY IN PRIMARY PREVENTION: DATA FROM THE JUPITER TRIAL

✍ Scribed by Ridker, Paul M.; MacFadyen, Jean G.; Chasman, Daniel I.

Book ID: 122560103
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 240 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(11)61199-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

37: KIF6 TRP719ARG polymorphism and effe

37: KIF6 TRP719ARG polymorphism and effect of statin therapy in the elderly: Results from the prosper trial

✍ He, Chengjian; Tian, Qinghua; Wu, Chun-gen; Gu, Yifeng; Wang, Tao; Li, Minghua 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 79 KB

Cardiovascular benefits and diabetes ris

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

✍ Paul M Ridker; Aruna Pradhan; Jean G MacFadyen; Peter Libby; Robert J Glynn 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 322 KB

Cardiovascular Benefits and Diabetes Ris

Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention: An Analysis From the JUPITER Trial

✍ Ridker, P.M.; Pradhan, A.; MacFadyen, J.G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Race, ethnicity, and the efficacy of ros

Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial

✍ Michelle A. Albert; Robert J. Glynn; Francisco A.H. Fonseca; Alberto J. Lorenzat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB

KIF6 Trp719Arg polymorphism and the effe

KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study

✍ Iakoubova, Olga A.; Robertson, Michele; Tong, Carmen H.; Rowland, Charles M.; Ca 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 318 KB

Justification for the Use of Statins in

Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?

✍ Samia Mora; Paul M. Ridker 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 374 KB